QQ客服 官方微博 反馈留言

	Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine
	Dai, Chun-Hua[1]; Wang, Yi[2]; Chen, Ping[3]; Jiang, Qian[4]; Lan, Ting[5]; Li, Mei-Yu[6]; Su, Jin-Yu[7]; Wu, Yan[8]; Li, Jian[9]
刊名	SCIENTIFIC REPORTS
	2017
卷号	7期号:1页码:15031
ISSN号	2045-2322
DOI	http://dx.doi.org/10.1038/s41598-017-15172-4
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000414647800003
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5346770
专题	江苏大学
作者单位	1.[1]Jiangsu Univ, Affiliated Hosp, Dept Radiat Oncol, Zhenjiang, Peoples R China. 2.[2]Jiangsu Univ, Affiliated Hosp, Ctr Expt Med, Zhenjiang, Peoples R China. 3.[3]Jiangsu Univ, Affiliated Hosp, Dept Pulm Med, Zhenjiang, Peoples R China. 4.[4]Jiangsu Univ, Affiliated Hosp, Ctr Expt Med, Zhenjiang, Peoples R China. 5.[5]Jiangsu Univ, Inst Med Sci, Zhenjiang, Jiangsu, Peoples R China. 6.[6]Jiangsu Univ, Affiliated Hosp, Dept Pulm Med, Zhenjiang, Peoples R China. 7.[7]Jiangsu Univ, Affiliated Hosp, Dept Pulm Med, Zhenjiang, Peoples R China. 8.[8]Jiangsu Univ, Inst Med Sci, Zhenjiang, Jiangsu, Peoples R China. 9.[9]Jiangsu Univ, Affiliated Hosp, Dept Pulm Med, Zhenjiang, Peoples R China.
推荐引用方式 GB/T 7714	Dai, Chun-Hua[1],Wang, Yi[2],Chen, Ping[3],et al. Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine[J]. SCIENTIFIC REPORTS,2017,7(1):15031.
APA	Dai, Chun-Hua[1].,Wang, Yi[2].,Chen, Ping[3].,Jiang, Qian[4].,Lan, Ting[5].,...&Li, Jian[9].(2017).Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine.SCIENTIFIC REPORTS,7(1),15031.
MLA	Dai, Chun-Hua[1],et al."Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine".SCIENTIFIC REPORTS 7.1(2017):15031.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。